Yulong Wang

2.1k citations
63 papers · 921 indexed · h-index 18
Topics
Thyroid Cancer Diagnosis and Treatment (33 papers)Thyroid and Parathyroid Surgery (7 papers)BRCA gene mutations in cancer (5 papers)
Partner nations
ChinaUnited StatesRussia

In The Last Decade

Yulong Wang

60 papers receiving 913 citations

Peers

Yulong Wang
Comparison fields: 5 of 93
  • Endocrinology, Diabetes and Metabolism 399
  • Molecular Biology 229
  • Oncology 214
  • Surgery 202
  • Pulmonary and Respiratory Medicine 198
Replace Kunio Yoshizawa with:
Kunio Yoshizawa Japan
Kazuhiko Asanuma Japan
Ho-Ryun Won South Korea
Xianghui He China
Hakmin Lee South Korea
Tetsuo Taniguchi Japan
Zvonimir L. Milas United States
Naoki Haraguchi Japan
Yulong Wang relative to Kunio Yoshizawa Japan Kunio Yoshizawa's profile →
Citations per field
00.5×3.2×
Kunio Yoshizawa · 1×
Citations per year

Countries citing papers authored by Yulong Wang

Since Specialization
Citations

This map shows the geographic impact of Yulong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulong Wang more than expected).

Fields of papers citing papers by Yulong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulong Wang. The network helps show where Yulong Wang may publish in the future.

Co-authorship network of co-authors of Yulong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yulong Wang. A scholar is included among the top collaborators of Yulong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulong Wang. Yulong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 10
4 1
5 2
6 17
7 3
8 9
9 6
10 14
11 17
12 32
13 1
14 17
15 26
16 17
17 4
18 47
19 12
20 11

About Yulong Wang

Yulong Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Otorhinolaryngology and Process Chemistry and Technology, having authored 63 papers that have together received 921 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (33 papers), Thyroid and Parathyroid Surgery (7 papers) and BRCA gene mutations in cancer (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (399 citations), Cancer Research (132 citations) and Oncology (214 citations). Yulong Wang has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Zhong‐Wu Lu, Qinghai Ji, Wenjun Wei, Ben Ma, Tian Liao, Ning Qu, Qinghai Ji, Duo Wen, Rong‐Liang Shi and Jia‐Qian Hu. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026